METHODS: We carried out a systematic review according to Cochrane and PRISMA recommendations. We searched in EMBASE, Medline (Ovid), and The Cochrane Central Register of Controlled Trials (CENTRAL), from inception to nowadays. We included case-control studies. The risk of bias assessment was performed based on QUADAS2. We performed a random effect Meta-analysis.
RESULTS: We included 14 studies in qualitative and quantitative analysis. There was mainly a low risk of bias. We finally found a strong association between the presence of HPV and bladder cancer diagnosis (OR 4.18 95%CI 2.63-6.66; I2 = 40%).
CONCLUSIONS: HPV is currently associated with the diagnosis of bladder cancer.
方法:我们根据Cochrane和PRISMA的建议进行了系统评价。我们在EMBASE搜索,Medline(Ovid),和Cochrane中央控制试验登记册(CENTRAL),从开始到现在。我们纳入了病例对照研究。基于QUADAS2进行偏倚风险评估。我们进行了随机效应Meta分析。
结果:我们纳入了14项定性和定量分析研究。主要存在低偏倚风险。我们最终发现HPV的存在与膀胱癌诊断之间存在很强的相关性(OR4.1895CI2.63至6.66;I2=40%)。
结论:HPV目前与膀胱癌的诊断相关。